|

ST-067 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Simcha IL-18, Inc.1

Indications

  • MSI-High1
  • Squamous Cell Carcinoma of the Head and Neck1
  • Carcinoma1
  • Renal Cell Carcinoma1
  • Triple Negative Breast Cancer1

Scottsdale, Arizona1 trial

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

HonorHealth Research Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.